id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2025-P-1807-0369,FDA,FDA-2025-P-1807,Amendment and Supplement from Interest of Justice,Other,Amendment,2026-09-30T04:00:00Z,2026,9,2026-09-30T04:00:00Z,,2026-11-07T00:12:45Z,,0,0,09000064b95f0cdd FDA-2025-P-1807-0368,FDA,FDA-2025-P-1807,Response Letter,Other,Response(s),2026-09-15T04:00:00Z,2026,9,2026-09-15T04:00:00Z,,2026-09-15T19:11:17Z,,0,0,09000064b955ee1b FDA-2025-P-1807-0365,FDA,FDA-2025-P-1807,Interim Response to Interest of Justice,Other,Response(s),2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T21:12:16Z,,0,0,09000064b90c915d FDA-2025-P-1807-0033,FDA,FDA-2025-P-1807,21a - Executive Order 13139 Wikisource the free online library,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:35:11Z,,0,0,09000064b8e1f1d8 FDA-2025-P-1807-0038,FDA,FDA-2025-P-1807,24 - National Security Presidential Memorandum NSPM 2 The White House,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:36:22Z,,0,0,09000064b8e1f1fc FDA-2025-P-1807-0040,FDA,FDA-2025-P-1807,25 - STATUTE 67 Pg. 631,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:36:41Z,,0,0,09000064b8e1f201 FDA-2025-P-1807-0020,FDA,FDA-2025-P-1807,12a - U.S. Department of Defense _ Contract,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:28:11Z,,0,0,09000064b8e1d4a3 FDA-2025-P-1807-0009,FDA,FDA-2025-P-1807,3 - Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derive,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:25:58Z,,0,0,09000064b8e1dd5b FDA-2025-P-1807-0015,FDA,FDA-2025-P-1807,8- Moderna Inc 2018 form S1 registration statement US securities and Exchange Commission_compressed,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:27:09Z,,0,0,09000064b8e3d122 FDA-2025-P-1807-0025,FDA,FDA-2025-P-1807,15a - GAO-21-387 highlights,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:33:00Z,,0,0,09000064b8e1f1c8 FDA-2025-P-1807-0027,FDA,FDA-2025-P-1807,16a - GAO 21 108 Highlights DEFENSE PRODUCTION ACT Opportunities Exist to Increase Transparency and Identify Future Actions,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:33:31Z,,0,0,09000064b8e1f1cc FDA-2025-P-1807-0034,FDA,FDA-2025-P-1807,22 - Executive Order 13989 Ethics Commitments by Executive Branch Personnel The American Presidency Project,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:35:34Z,,0,0,09000064b8e1f1f0 FDA-2025-P-1807-0011,FDA,FDA-2025-P-1807,5 - Journal of Molecular Biology _ ScienceDirect_com by Elsevier,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:26:20Z,,0,0,09000064b8e1d49d FDA-2025-P-1807-0019,FDA,FDA-2025-P-1807,12 - Pfizer-Inc.-Covid-19-Vaccine-Contract,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:28:01Z,,0,0,09000064b8e1d4a2 FDA-2025-P-1807-0016,FDA,FDA-2025-P-1807,9 - ii Moderna Inc 2019 Form 10K annual Report US Securities and Exchange Commission_compressed,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:27:25Z,,0,0,09000064b8e3d219 FDA-2025-P-1807-0017,FDA,FDA-2025-P-1807,10 - iii NioNtech SE 2019 Form F1 Registration Statement US Securities And Exchange Commission_compressed,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:27:39Z,,0,0,09000064b8e3d21e FDA-2025-P-1807-0012,FDA,FDA-2025-P-1807,6 - Nature Biotechnology,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:26:31Z,,0,0,09000064b8e1d49e FDA-2025-P-1807-0018,FDA,FDA-2025-P-1807,11 - Opening Ceremony World Health Summit 2021 Speech Stefan Oelrich,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:27:52Z,,0,0,09000064b8e1d4a1 FDA-2025-P-1807-0021,FDA,FDA-2025-P-1807,13 - Award Contract No W911QY20C0100 by and between Moderna US Moderna Inc. - Business Contracts Justia,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:28:21Z,,0,0,09000064b8e1f1c4 FDA-2025-P-1807-0024,FDA,FDA-2025-P-1807,15 - GAO-21-387_compressed,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:29:00Z,,0,0,09000064b8e1f1c7 FDA-2025-P-1807-0030,FDA,FDA-2025-P-1807,19 - Advanced Biological Research Group to Study Effects of mRNA on Women's Reproduction _ Morningstar,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:34:35Z,,0,0,09000064b8e1f1d5 FDA-2025-P-1807-0031,FDA,FDA-2025-P-1807,20 - Whistleblower Doctor Drops Bombshell on mRNA COVID19 Vaccines But Whats the Evidence,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:34:46Z,,0,0,09000064b8e1f1d6 FDA-2025-P-1807-0032,FDA,FDA-2025-P-1807,21 - 64 FR 54175 Improving Health Protection of Military Personnel Participating in Particular Military Operations Content Details,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:34:56Z,,0,0,09000064b8e1f1d7 FDA-2025-P-1807-0036,FDA,FDA-2025-P-1807,23 - Executive Order 14102 Ordering the Selected Reserve and Certain Members of the Individual Ready Reserve of the Armed Forces to,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:35:57Z,,0,0,09000064b8e1f1f6 FDA-2025-P-1807-0004,FDA,FDA-2025-P-1807,1 - Evidence of admin remedy absolved IOJ Cit Pet 2023 FDA_compressed,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T22:37:42Z,,0,0,09000064b8e1dd56 FDA-2025-P-1807-0005,FDA,FDA-2025-P-1807,WHO Ethics Complaints Sept 18 2024 To MDS EUL Referred to National Authority,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:24:46Z,,0,0,09000064b8e1dd57 FDA-2025-P-1807-0006,FDA,FDA-2025-P-1807,1 - Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:25:00Z,,0,0,09000064b8e1dd58 FDA-2025-P-1807-0008,FDA,FDA-2025-P-1807,2025-05-21-Chairman-Ron-Johnson-Opening-Statement-FINAL,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:25:44Z,,0,0,09000064b8e1dd5a FDA-2025-P-1807-0022,FDA,FDA-2025-P-1807,13a - U.S. Department of Defense _ Contract,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:28:35Z,,0,0,09000064b8e1f1c5 FDA-2025-P-1807-0029,FDA,FDA-2025-P-1807,18 - 2021-04-08_Clyburn to Hatfill re PPE,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:34:23Z,,0,0,09000064b8e1f1d4 FDA-2025-P-1807-0037,FDA,FDA-2025-P-1807,23a - Federal Register Ordering the Selected Reserve and Certain Members of the Individual Ready Reserve of the Armed Forces to Acti,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:36:10Z,,0,0,09000064b8e1f1fb FDA-2025-P-1807-0003,FDA,FDA-2025-P-1807,1 - Department of Defense - FOIA Requests from IOJ,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T22:06:35Z,,0,0,09000064b8e1dd55 FDA-2025-P-1807-0001,FDA,FDA-2025-P-1807,Acknowledgment Letter from FDA DMB to Interest of Justice,Other,Acknowledgement Letter/Receipt,2025-06-27T04:00:00Z,2025,6,2025-06-27T04:00:00Z,,2025-06-27T22:04:17Z,,0,0,09000064b8e1ef83 FDA-2025-P-1807-0002,FDA,FDA-2025-P-1807,Petition for Reclassification from Interest of Justice,Other,Petition(s),2025-06-27T04:00:00Z,2025,6,2025-06-27T04:00:00Z,,2025-12-18T10:00:13Z,,1,0,09000064b8e1ef7d FDA-2025-P-1807-0010,FDA,FDA-2025-P-1807,4 - Current Issues in Molecular Biology _ An Open Access Journal from MDPI,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:26:07Z,,0,0,09000064b8e1d49c FDA-2025-P-1807-0013,FDA,FDA-2025-P-1807,7 - Genome-wide host-pathogen analyses reveal genetic interaction points in tuberculosis disease _ Nature Communications,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:26:44Z,,0,0,09000064b8e1d49f FDA-2025-P-1807-0007,FDA,FDA-2025-P-1807,2 - Immune imprinting breadth of variant recognition and germinal center response in human SARS CoV2 infection and vaccination Cell,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:25:15Z,,0,0,09000064b8e1dd59 FDA-2025-P-1807-0023,FDA,FDA-2025-P-1807,14 - JAMS_7_Packard,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:28:49Z,,0,0,09000064b8e1f1c6 FDA-2025-P-1807-0028,FDA,FDA-2025-P-1807,17 - Steven Hatfill Dana parish They Lied,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:33:43Z,,0,0,09000064b8e1f1cf FDA-2025-P-1807-0039,FDA,FDA-2025-P-1807,24a - National Security Memorandum (NSM) on Artificial Intelligence Democracy Tech Initiative Markup - DFRLab,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:36:31Z,,0,0,09000064b8e1f1fd FDA-2025-P-1807-0041,FDA,FDA-2025-P-1807,26 - RFK Jr. seeks to remove COVID-19 vaccine recommendation for children,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:36:50Z,,0,0,09000064b8e1f202 FDA-2025-P-1807-0014,FDA,FDA-2025-P-1807,8 - Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine _ New England Journal of Medicine,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:26:58Z,,0,0,09000064b8e1d4a0 FDA-2025-P-1807-0026,FDA,FDA-2025-P-1807,16 - GAO 21 108 DEFENSE PRODUCTION ACT Opportunities Exist to Increase Transparency and Identify Future Actions to Mitigate Medical,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:33:14Z,,0,0,09000064b8e1f1ca FDA-2025-P-1807-0035,FDA,FDA-2025-P-1807,22a - Federal Register Initial Rescissions of Harmful Executive Orders and Actions,Supporting & Related Material,Background Material,2025-06-27T04:00:00Z,2025,6,,,2025-06-27T19:35:44Z,,0,0,09000064b8e1f1f5